InsidersTradesSigma
Browse the full record of transactions filed by Simonian Nancy A, Chairman & CEO. Insider active across 2 companies, notably Seagen Inc.. Cumulatively, 5 disclosures have been published. The latest transaction was disclosed on 13 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
5 of 5 declarations
Nancy A. Simonian is the President and CEO of Seagen Inc. and Syros Pharmaceuticals, Inc. She leads both companies with a vision focused on innovation and research. Her leadership is essential for achieving the strategic and operational objectives of these organizations.